Table 1.
Clinicopathologic Characteristics of Study Participants
| All Cases (n=138) | |
|---|---|
| Gender, n (%) | |
| Female | 38 (28) |
| Male | 100 (72) |
| Age at Diagnosis (years) | |
| Range | 32–91 |
| Mean (SD) | 61 (12.0) |
| HPV16 E6 Serology, n (%)* | |
| Positive | 12 (12) |
| Negative | 92 (88) |
| Tumor Site, n (%) † | |
| Oral | 76 (64) |
| Pharynx | 24 (20) |
| Larynx | 19 (16) |
| Clinical Stage, n (%) ‡ | |
| I | 9 (7) |
| II | 27 (21) |
| III | 24 (19) |
| IV | 67 (53) |
| Lifetime Drink-Years of Consumption, n § | |
| Range | 0–61 |
| Mean (SD) | 26 (20) |
| Never-drinkers, n | 34 |
| Lifetime Pack-Years Smoked, n || | |
| Range | 0–135 |
| Mean (SD) | 35 (31) |
| Never-smokers, n | 20 |
*
Thirty-four samples missing serology data
†
Nineteen samples missing site data
‡
Eleven tumors missing stage data
§
Twenty-two patients missing self-reported drinking data
||
Seventeen patients missing self-reported smoking data